Sasanka Nutra & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 3 Months
- Open Charges ₹ 0.79 M
About Sasanka Nutra & Pharmaceuticals
Sasanka Nutra & Pharmaceuticals Private Limited (SNPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 October 2012 and has a history of 12 years and three months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.79 M.
Kunaparaju Rambabu and Madhu Kunaparaju serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TG2012PTC083470
-
Company No.
083470
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Oct 2012
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sasanka Nutra & Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunaparaju Rambabu
|
Director | 05-Oct-2012 | Current |
|
Madhu Kunaparaju
|
Director | 05-Oct-2012 | Current |
Financial Performance of Sasanka Nutra & Pharmaceuticals.
Enhance accessibility to Sasanka Nutra & Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sasanka Nutra & Pharmaceuticals?
Unlock access to Sasanka Nutra & Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sasanka Infra Projects Private LimitedKunaparaju Rambabu and Madhu Kunaparaju are mutual person
Charges (Loans)
₹0.79 M
₹0
Charges Breakdown by Lending Institutions
- The Karur Vysya Bank Limited : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Oct 2012 | The Karur Vysya Bank Limited | ₹0.79 M | Open |
How Many Employees Work at Sasanka Nutra & Pharmaceuticals?
Unlock and access historical data on people associated with Sasanka Nutra & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sasanka Nutra & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sasanka Nutra & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
